Literature DB >> 7675035

Nuclear proteins that interact with the beta maj globin promoter start to accumulate in MEL cells within 12 hours of induction and RNA copies of the promoter successfully compete their binding in vitro.

L Sun-Hoffman1, I Winicov.   

Abstract

The induction of differentiation in mouse erythroleukemia (MEL) cells by dimethylsulfoxide (DMSO) is characterized by increased transcription of globin genes. We have determined that DMSO treated cells increase the levels of nuclear factors capable of overall interactions with the beta maj globin promoter during the initial 24 h post induction, as measured by gel mobility analysis. Two unprocessed beta maj globin mRNA precursors, which are present in MEL cell nuclei early in differentiation, were previously shown to contain the 5' promoter flanking region, and thereby provided the nucleus with a pool of regulatory sequences in multiple RNA copies. We have studied the effect of RNA copies of the promoter region on binding interactions between DNA sequences of the beta maj globin promoter and nuclear factors that interact with these sequences. The promoter region RNA transcripts competed effectively for DNA binding proteins in vitro, while the antisense RNA from the same region did not. The most pronounced competition was observed with proteins from 12 h after DMSO induction, when the concentration of the DNA binding proteins was still increasing. Since the 'upstream' transcripts predominate at 12 h after DMSO induction, these results indicate that the promoter region transcripts may influence the equilibrium of binding between the beta maj globin promoter and the nuclear factors that bind to this region during DMSO induction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675035     DOI: 10.1007/bf00935488

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  51 in total

Review 1.  Control of globin gene transcription.

Authors:  T Evans; G Felsenfeld; M Reitman
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Derepression of mouse beta-major-globin gene transcription during erythroid differentiation.

Authors:  K Macleod; M Plumb
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

3.  The human beta-globin gene 3' enhancer contains multiple binding sites for an erythroid-specific protein.

Authors:  L Wall; E deBoer; F Grosveld
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

4.  Erythroid-specific activation and derepression of the chick beta-globin promoter in vitro.

Authors:  B M Emerson; J M Nickol; T C Fong
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

5.  Fine structure genetic analysis of a beta-globin promoter.

Authors:  R M Myers; K Tilly; T Maniatis
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

6.  Association of the adenovirus DNA-binding protein with RNA both in vitro and in vivo.

Authors:  V G Cleghon; D F Klessig
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  DNase I hypersensitive sites of globin genes of uninduced Friend erythroleukemia cells and changes during induction with dimethyl sulfoxide.

Authors:  J M Balcarek; F A McMorris
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

8.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner; R Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Human beta-globin promoter and coding sequences transcribed by RNA polymerase III.

Authors:  D P Carlson; J Ross
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

10.  Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.

Authors:  E H Postel; S J Flint; D J Kessler; M E Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.